Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 17Radiotherapy 5Bevacizumab 5Filgrastim 4vocimagene amiretrorepvec 3sargramostim 3etoposide phosphate 3antineoplaston AS 2-1 3antineoplaston A10 3Surgical Procedures, Operative 3O(6)-benzylguanine 3Melphalan 3Lomustine 3Flucytosine 3Dynamic Contrast Enhanced Magnetic Resonance Imaging 3Carmustine 3Aminolevulinic Acid 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3tovorafenib 2palbociclib 2cabozantinib 2Vorinostat 2Topotecan 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Astrocytoma × laromustine × Clear all
NCT00516282 2011-08-26

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Northwestern University

Phase 1 Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡